SyntekaBio Inc (226330) — Strategic Asset Allocation Index
SyntekaBio Inc (226330) has a Strategic Asset Allocation Index of 170.2% as of March 2025. Strategic assets (PP&E of ₩30.18 Billion plus long-term investments of ₩-) total ₩30.18 Billion, measured against net assets of ₩17.73 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check SyntekaBio Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
SyntekaBio Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how SyntekaBio Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of March 2025, the index stands at 170.2%, representing strategic assets of ₩30.18 Billion against net assets of ₩17.73 Billion KRW. See financial agility of SyntekaBio Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for SyntekaBio Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for SyntekaBio Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of SyntekaBio Inc.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 55.5% | ₩17.47 Billion | ₩17.47 Billion | ₩- | ₩31.46 Billion | ▲ +22.8 pp |
| 2021 | 32.8% | ₩9.05 Billion | ₩9.05 Billion | ₩- | ₩27.63 Billion | ▲ +26.6 pp |
| 2020 | 6.2% | ₩2.58 Billion | ₩2.58 Billion | ₩- | ₩41.54 Billion | ▲ +2.4 pp |
| 2019 | 3.8% | ₩1.74 Billion | ₩1.74 Billion | ₩- | ₩46.11 Billion | ▼ -55.4 pp |
| 2018 | 59.2% | ₩971.67 Million | ₩971.67 Million | ₩- | ₩1.64 Billion | — |